Oligonucleotide and peptide purification technology on show at TIDES USA in May 2022

1 min read

In May 2022, DuPont will be showcasing its extensive portfolio of polymeric resin technologies for the bioprocessing market at TIDES USA, the world’s leading event for oligonucleotide and peptide therapeutics.

In May 2022, DuPont will be showcasing its extensive portfolio of polymeric resin technologies for the bioprocessing market at TIDES USA, the world’s leading event for oligonucleotide and peptide therapeutics.

Key members of the DuPont Life Sciences team will be attending the event, demonstrating how the company’s chromatography resins and fine mesh ion exchange products can be used for the efficient separation and purification of oligonucleotides and peptides.

Three of DuPont´s scientists will present posters during the conference, exploring the important role of resins in bioprocessing and how specially designed products for the life sciences industry can be used to deliver durable and scalable processes:

  • Daryl Gisch, Research Scientist will present a poster exploring how DuPont AmberChrom Ion Exchange resins can be used for chromatographic separation of peptides and oligonucleotide columns. Offering exceptional selectivity, consistency, and reliability.
  • Martin Deetz, Technical Laureate will represent a poster comparing the performance of different reverse-phase resins when used for preparative oligonucleotide separations and a poster about how to design HPLC conditions to do an oligo separation.

"We’re looking forward to engaging with customers and research partners at TIDES USA, discussing how our technologies can address challenges within the rapidly evolving oligonucleotide and peptide markets,” said Dorie Yontz, Global Marketing Manager Bioprocessing at DuPont Water Solutions. As a global market leader in adsorbents and ion exchange resins, we have been developing solutions to address complicated separations and purifications since the 1950s. Every day, DuPont technical Service and development teams across the globe work hand in hand with scientists at our industry partners to help them develop and scale-up high-purity, high-yield chromatography processes. We are continually striving to ensure we are positioned to support the development and commercialization of breakthrough diagnostic and therapeutic solutions."